Medicare Enrolled

Dr. James Adamo, M.D.

Psychiatry · Roseville, MI
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
25509 KELLY RD STE A, Roseville, MI 48066
5862522616
Registered in NPPES since 2006
NPI: 1851311021 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Adamo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Adamo? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Adamo

Dr. James Adamo is a psychiatry specialist in Roseville, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Adamo performed 2,615 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Adamo received a total of $23,871 from 46 pharmaceutical and/or device companies across 1497 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Adamo is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ Top 1% volume in MI $23,871 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
2,615
Medicare services
Top 1% in MI for psychiatry
Not available
Unique patients (not deduplicated)
$58
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
923 $95 $136
Assessment of emotional or behavioral problems
An evaluation to identify and understand emotional or behavioral issues. This process involves reviewing symptoms and behaviors to determine the nature of the concerns.
766 $4 $25
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
446 $62 $80
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
256 $57 $95
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
66 $89 $114
Hospital discharge day management, 30 minutes or less
This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less.
64 $65 $109
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
36 $101 $175
Psychotherapy and evaluation, 30 minutes
A combined session involving psychotherapy and an evaluation and management visit lasting 30 minutes.
23 $55 $101
Psychiatric diagnostic evaluation with medical services
A psychiatric assessment that includes medical services to evaluate mental health conditions.
20 $149 $302
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
15 $115 $191
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$23,871
Total received (2018-2024)
Avg $3,410/year across 7 years
Top 2% in MI for psychiatry
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
1,497
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$5,050
2023
$6,743
2022
$2,405
2021
$1,981
2020
$2,480
2019
$2,877
2018
$2,336

Payments by company (2024)

ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$607
ABBVIE INC.
$586
Teva Pharmaceuticals USA, Inc.
$548
Corium, LLC
$435
Sage Therapeutics, Inc.
$324
Otsuka America Pharmaceutical, Inc.
$314
Neurocrine Biosciences, Inc.
$306
Tris Pharma Inc
$289
Janssen Pharmaceuticals, Inc
$262
Alkermes, Inc.
$206
Lundbeck LLC
$192
IDORSIA PHARMACEUTICALS US INC
$162
Almatica Pharma LLC
$161
IRONSHORE PHARMACEUTICALS INC.
$159
Validus Pharmaceuticals LLC
$129
Supernus Pharmaceuticals, Inc.
$123
Neos Therapeutics, LP
$78
Takeda Pharmaceuticals U.S.A., Inc.
$56
Novo Nordisk Inc
$31
Noven Therapeutics, LLC
$23
Indivior Inc.
$22
Vanda Pharmaceuticals Inc.
$20
OWP Pharmaceuticals, Inc.
$17
Top 3 companies account for 34.5% of 2024 payments
All-time payments by company (2018-2024) ›
Teva Pharmaceuticals USA, Inc.
$2,472
Otsuka America Pharmaceutical, Inc.
$2,291
Neurocrine Biosciences, Inc.
$1,572
Janssen Pharmaceuticals, Inc
$1,571
Lundbeck LLC
$1,547
ITI, Inc.
$1,279
Sunovion Pharmaceuticals Inc.
$1,202
Corium, LLC
$1,091
Avanir Pharmaceuticals, Inc.
$1,084
AbbVie Inc.
$918
Alkermes, Inc.
$828
Takeda Pharmaceuticals U.S.A., Inc.
$807
ABBVIE INC.
$645
Tris Pharma Inc
$622
Vanda Pharmaceuticals Inc.
$617
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$607
Supernus Pharmaceuticals, Inc.
$556
Shire North American Group Inc
$465
IDORSIA PHARMACEUTICALS US INC
$413
Allergan, Inc.
$328
Sage Therapeutics, Inc.
$324
Indivior Inc.
$304
Validus Pharmaceuticals LLC
$292
Almatica Pharma LLC
$244
Neos Therapeutics, LP
$206
Allergan Inc.
$176
Ironshore Pharmaceuticals Inc.
$162
IRONSHORE PHARMACEUTICALS INC.
$159
Axsome Therapeutics, Inc.
$158
Bausch Health US, LLC
$157
Merck Sharp & Dohme LLC
$115
Eisai Inc.
$112
Adlon Therapeutics L.P.
$98
OWP Pharmaceuticals, Inc.
$77
JAZZ PHARMACEUTICALS INC.
$63
Merck Sharp & Dohme Corporation
$40
BioXcel Therapeutics, Inc.
$40
Jazz Pharmaceuticals Inc.
$36
Pernix Therapeutics Holdings, Inc.
$35
Novo Nordisk Inc
$31
Noven Therapeutics, LLC
$23
ARBOR PHARMACEUTICALS, INC.
$22
Janssen Biotech, Inc.
$22
Alfasigma USA, Inc.
$22
Neuronetics, Inc.
$20
ACADIA Pharmaceuticals Inc
$18
Top 3 companies account for 26.5% of all-time payments
Associated products mentioned in payments ›
ABILIFY ASIMTUFII · ABILIFY MAINTENA · ABILIFY MYCITE · ADHANSIA XR · APLENZIN · ARISTADA · AUSTEDO · AZSTARYS · Adzenys XR-ODT · Austedo XR · Auvelity · Azstarys · BELSOMRA · BRINTELLIX · CAPLYTA · Dayvigo · Dyanavel XR · Equetro · Evekeo · FANAPT · HETLIOZ · IGALMI · INGREZZA · INVEGA SUSTENNA · INVEGA TRINZA · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · LATUDA · LOREEV XR · LYBALVI · Lamotrigine Starter Kit · MIGRANAL · MYDAYIS · NEUROSTAR TMS THERAPY · NEUROSTAR TMS THERAPY SYSTEM · NUEDEXTA · NUPLAZID · Nuedexta · PERSERIS · QELBREE · QUVIVIQ · Qelbree · REXULTI · SILENOR · SPRAVATO · SUBLOCADE · SUNOSI · Subvenite · TRINTELLIX · Trintellix · UZEDY · VIVITROL · VRAYLAR · VYEPTI · VYVANSE · WELLBUTRIN · Wegovy · Xelstrym · ZURZUVAE
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a psychiatry specialist in Roseville?
Compare psychiatrists in the Roseville area by procedure volume, costs, and industry payment transparency.
Browse psychiatrists nearby

Geographic Context

Psychiatrists in nearby ZIP areas
506
County median income
$76,399
Nearest hospital to ZIP centroid (approximate)
Henry Ford Health Warren Hospital
4.1 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Adamo is a clinical cardiology specialist, with above-average Medicare volume (top 1% in MI), with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Adamo experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Adamo performed 923 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Adamo receive payments from pharmaceutical companies?
Yes. Dr. Adamo received a total of $23,871 from 46 companies across 1,497 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Adamo's costs compare to other psychiatrists in Roseville?
Dr. Adamo's average Medicare payment per service is $58. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Adamo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →